Related Experiment Video
Updated: Aug 12, 2026
14:28
Peptide-based Identification of Functional Motifs and their Binding Partners
Published on: July 1, 2013
Self antigen prognostic for human immunodeficiency virus disease progression
C L Bristow1, H Patel, R R Arnold
1Department of Pathology and Laboratory Medicine, University of North Carolina-Chapel Hill, Chapel Hill, NC 27514, USA. bristoc@mail.rockefeller.edu
Clinical and Diagnostic Laboratory Immunology
|August 31, 2001
Summary
Alpha-1 proteinase inhibitor (alpha-1 PI) deficiency is common in HIV patients and linked to lower viral load. Addressing this deficiency may be key to managing HIV disease progression and related complications.
Area of Science:
- Immunology
- Virology
- Pulmonology
Background:
- Extracellular protein alpha-1 proteinase inhibitor (alpha(1)PI), also known as alpha(1) antitrypsin, plays a role in human immunodeficiency virus (HIV) infectivity.
- Alpha-1 PI deficiency is a known risk factor for degenerative lung diseases and reduced lifespan.
Purpose of the Study:
- To investigate the correlation between circulating alpha(1)PI levels and viral load in HIV-seropositive patients.
- To determine the prevalence of alpha(1)PI deficiency in different stages of HIV disease.
- To explore the relationship between HIV-associated alpha(1)PI deficiency and anti-alpha(1)PI immunoglobulin G.
Main Methods:
- Analysis of circulating alpha(1)PI levels in HIV-seropositive patients.
- Correlation analysis between alpha(1)PI levels and viral load.
- Assessment of anti-alpha(1)PI immunoglobulin G levels.
Main Results:
- Decreased viral load in HIV patients is significantly correlated with decreased circulating alpha(1)PI.
- 100% of asymptomatic HIV patients exhibit deficient levels of active alpha(1)PI.
- HIV-associated alpha(1)PI deficiency is correlated with the presence of circulating anti-alpha(1)PI immunoglobulin G.
Conclusions:
- Alpha-1 PI deficiency is a significant finding in HIV-seropositive individuals, even in asymptomatic stages.
- Preventing or treating HIV-associated alpha(1)PI deficiency may represent a novel therapeutic strategy for mitigating HIV pathophysiology.
- Further research is warranted to explore the clinical implications of alpha(1)PI deficiency in HIV management.
Related Concept Videos
01:25Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
01:26Sexually Transmitted Infections
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...